Van Eck Associates Corp Axsome Therapeutics, Inc. Transaction History
Van Eck Associates Corp
- $77.4 Billion
- Q1 2025
A detailed history of Van Eck Associates Corp transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 62,995 shares of AXSM stock, worth $6.32 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
62,995Holding current value
$6.32 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
406Shares Held
36.2MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$389 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$331 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$293 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$170 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$98 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.3B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...